Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism
about
TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activationStimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling systemA fourth IkappaB protein within the NF-kappaB signaling moduleAutoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunitySelf-termination of the terminatorMutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficienciesNF-kappaB: a multifaceted transcription factor regulated at several levelsNIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activationZingerone suppresses liver inflammation induced by antibiotic mediated endotoxemia through down regulating hepatic mRNA expression of inflammatory markers in Pseudomonas aeruginosa peritonitis mouse modelTWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.Exploring the Potential of Venom from Nasonia vitripennis as Therapeutic Agent with High-Throughput Screening ToolsB cell TLRs and induction of immunoglobulin class-switch DNA recombination.Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes.Circuitry of nuclear factor kappaB signaling.Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.Identification of novel focal adhesion kinase substrates: role for FAK in NFκB signalingExodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection.Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection.Functions of NF-kappaB1 and NF-kappaB2 in immune cell biologyFbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.Hydrogen peroxide modulates immunoglobulin expression by targeting the 3'Igh regulatory region through an NFκB-dependent mechanismLipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B LymphocytesActivation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells.The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesisMonarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functionsNF-kappa B as a therapeutic target in autoimmune disease.Inducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulationLymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.Crosstalk via the NF-kappaB signaling system.Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity.Putative RNA-Directed Adaptive Mutations in Cancer Evolution.A single NFκB system for both canonical and non-canonical signaling.Non-canonical NF-κB signaling pathway.How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
P2860
Q24297399-CC55301C-0431-495D-AA0F-E8EE9F0F59B0Q24316194-E521C4C7-28CB-46F7-90D2-ABA18B241D57Q24641914-9B8A0B85-A54B-477C-8AD8-A9E93D1C2F5EQ24676472-FFDAE194-C1DC-4C36-8570-DCB9CD982B0BQ24684338-D0959C1B-C2B5-44EE-AD88-13D1C3078DAFQ28118772-884A600F-5C87-4B72-84A6-6532A73779F6Q28254194-8E1D6C25-382D-48B2-840D-0E200CE6FCDCQ28285466-397D5D73-36C8-4DC5-919F-EB7F4DDA98B9Q28508229-B15E0068-F5E4-4F87-AEDB-41FED651D755Q28542902-2AD4A8E1-A48C-445D-9D77-6B45C9400657Q31148506-129D28E3-85DF-4C45-9C6A-CD4B0C0359F0Q33360864-77BBD0D7-DBC0-4D59-9336-A28C3791BC5BQ33893517-314E3031-B73F-4707-9368-BCD4388AA3C3Q34330967-C84DD3DC-B4D6-453A-A47A-F5965109FA32Q34514908-448BAC2D-FE4A-4479-B2C9-85DF5D0C7525Q34997519-CD7222A7-08E2-4ADD-A531-E76768CCDC06Q35121711-E198AF87-89C5-4ADE-BC0A-FA26DF285155Q35126481-77301B7B-3834-4FBD-A98F-BFB0DB0C43FEQ35197497-C43CC5C9-A404-4513-A0BC-17B797274B97Q35238598-89CAF4D8-61FF-4F5E-92F3-955968F46F24Q35319917-CED45FCD-1041-4926-9ABD-0E9F28CBA114Q35608607-E25D43FD-59CD-4E47-8329-DD4FC0BF1CE7Q35815962-4FE64330-0903-46D6-9BB1-1A0B415EE399Q35919057-A972FD46-4141-4916-9FD1-D8E86BD00B8EQ35983657-3B42F1A8-FA47-42CC-99D8-24B01989D9EDQ36097312-5BAD15A2-A888-4219-A8D0-FA5C10538B68Q36213003-5438595C-3253-493C-BE28-51D3ED194D1DQ36246200-DB92BB9B-263C-4205-BFA5-1A3869F18095Q36371653-1B882183-BD36-42E3-870F-D1D4AB34EAF0Q36453716-4507B743-0213-4171-9CE8-2265EE295C1BQ36709522-3FB50624-4D77-4161-BF61-86C63805892FQ36850404-8D1F863B-DAFA-4FA3-A1FD-631A66997F18Q37000942-EAF80F96-C9AD-4189-8736-769AA15CC74DQ37178526-958F23F7-AE7F-473E-84DC-AA8E1E53EB22Q37239051-1061E989-64D6-49DB-9AE5-43501312586FQ37343623-3368CA7B-AB1E-4B13-83D1-E3CEE40FB78CQ37811890-CF4D89A8-B5D5-41B7-9364-6674C1350492Q37822660-5767C7F6-F7B8-471E-98EE-EDB3534FE7EFQ37948116-52BA6E27-D5AC-4D56-8D8E-EBA0F81AF31EQ37948121-51BA073A-20EF-4A04-B04D-AED9E8BFF506
P2860
Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@ast
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@en
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@nl
type
label
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@ast
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@en
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@nl
prefLabel
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@ast
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@en
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@nl
P2093
P2860
P1433
P1476
Lymphotoxin and lipopolysaccha ...... y a co-translational mechanism
@en
P2093
Claus Scheidereit
Elmar Wegener
Meral Esen
P2860
P356
10.1038/SJ.EMBOR.EMBOR710
P577
2003-01-01T00:00:00Z